Re-eradication of Helicobacter pylori infection following initial treatment failure: treatment options in clinical practice.
Department of Gastroenterology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. moshkov7@zahav.net.il
Menachem
M
Moshkowitz
Zamir
Z
Halpern
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D005756:Gastritis / Q000188:drug therapy / Q000382:microbiology; D016481:Helicobacter Infections / Q000188:drug therapy* / Q000382:microbiology; D016480:Helicobacter pylori; D006801:Humans; D015201:Meta-Analysis as Topic; D008826:Microbial Sensitivity Tests; D017410:Practice Guidelines as Topic; D019233:Retreatment / Q000379:methods; D017211:Treatment Failure
D000900:Anti-Bacterial Agents; D000897:Anti-Ulcer Agents